Fidelity Investments’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.46M | Sell |
|
|||||
|
2025
Q2 | $27.3M | Buy |
|
|||||
|
2025
Q1 | $12.5M | Sell |
|
|||||
|
2024
Q4 | $11.6M | Buy |
|
|||||
|
2024
Q3 | $15.8M | Buy |
|
|||||
|
2024
Q2 | $9.24M | Buy |
|
|||||
|
2024
Q1 | $11.1M | Sell |
|
|||||
|
2023
Q4 | $6.59M | Sell |
|
|||||
|
2023
Q3 | $4.94M | Sell |
|
|||||
|
2023
Q2 | $31.3M | Sell |
|
|||||
|
2023
Q1 | $33.1M | Sell |
|
|||||
|
2022
Q4 | $45.8M | Buy |
|
|||||
|
2022
Q3 | $25.2M | Buy |
|
|||||
|
2022
Q2 | $15.8M | Sell |
|
|||||
|
2022
Q1 | $13.3M | Buy |
|
|||||
|
2021
Q4 | $25M | Sell |
|
|||||
|
2021
Q3 | $42.8M | Sell |
|
|||||
|
2021
Q2 | $145M | Sell |
|
|||||
|
2021
Q1 | $209M | Buy |
|
|||||
|
2020
Q4 | $156M | Buy |
|